Bioactive peptides in milk products

Italian Journal of Food Science

Volumn 9, Issue 2, 1997, Pages 91-98

  Tirelli, A ^a   De Noni, I ^a   Resmini, P ^a  

^a Dipto Sci Tecnologie Alimentari M   (Italy)

Author keywords

Biopeptides; Casein; Peptides; Review; Whey protein

Indexed keywords

EID: 0031485343     PISSN: 11201770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Addeo, F., Chianese, L., Salzano, A., Sacchi, R., Cappuccio, U., Ferranti, P. and Malorni, A. 1992. Characterization of the 12% trichloroacetic acidinsoluble oligopeptides of Parmigiano Reggiano cheese. J. Dairy Res. 59:401.
2. s1-casein using HPLC and ELISA. J. Biochem. 102:421.
3. Ariyoshi, Y, 1993. Angiotensin-converting enzyme inhibitors derived from proteins. Trends Food Sci. Tech. 4:139.
4. Bicknell, R. S. 1985. Endogenous opioid peptides and hypothalamic neuroendocrine neurons. S. Endocr. 107:43.
5. Bounous, G. and the late Amer, M. A. 1990. The immunoenhancing effect of dietary whey protein concentrate. In "Role of Milk Protein in Human Nutrition". Bulletin of the International Dairy Federation 253:3.
6. Brantl, V., Teschemacher, H., Hemschem A. and Lottspeich, F. 1979. Novel opioid peptides derived from casein (β-casomorphins). Z. Physiol. Chem. 360:1211.
7. Chiba, H. and Yoshikawa, M. 1986. Biologically functional peptides from food proteins: new opioid peptides from milk proteins. In: "Protein Tailoring for Food and Medical Uses." R.E. Feeney and J.R. Whitaker (Eds). Marcel Dekker. New York.
8. Fiat, A.-M., Migliore-Samour, D., Jollès, P., Drouet, L., Bal Dit Sollier, C. and Caen, J. 1993. Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. J. Dairy Sci. 76:301.
9. Gaucheron, F., Mollé, D. Léonil, J. and Maubois, J.-L. 1995. Selective determination of phosphopeptide β-CN (1-25) in a β-casein digest by adding iron: characterisation by liquid chromatography with on-line electrospray-ionization mass spectrometric detection. J. Chrom. 644:193.
10. Goepfert, A. and Meisel, H. 1996. Semi-preparative isolation of phosphopeptides derived from bovine casein and dephosphorylation of phosphopeptides. Nahrung 40:245.
11. Hahn, A., Erll, G., Sawataki, G. and Daniel, H. 1994. Does casein as precursor of β-casomorphins effect gastrointestinal transit time?. In "β-casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds), VCH-Weinheim, Germany.
12. Hagemeister, H., Sick, H. and Barth, C. A. 1990. Nitrogen balance in the human and effects of milk constituents. In: "Role of Milk Protein in Human Nutrition". Bulletin of the International Dairy Federation 253: 3.
13. Höllt, V. 1983 Multiple endogenous opioid peptides. Trends Neurosci. 6:24.
14. Ipp, E., Dhorjiwala, J., Pugh, W., Moossa, A. R. and Rubinstein, A. H. 1982. Effect of an enkephalin analog on pancreatic endocrine function and glucose homeostasis in normal and diabetic dogs. Endocrinology 111: 2110.
15. Jollés, P. and Henschen, A. 1982. Comparison between the clotting of blood and milk. Trends Biochem. Sci. 7: 325.
16. Jollés, P., Levy-Toledano, S., Fiat, A. M., Soria, C., Gillesen, D., Thomaidis, A., Dunn, F. W. and Caen, J. 1986. Analogy between fibrinogen and casein: effect of an undecapeptide isolated from κ-casein on platelet function. Eur. J. Biochem. 158:379.
17. Jollés, P., Parker, F., Floc'h, F., Migliore-Samour, D., Alliel, P., Zarial, A. and Werner, G. H. 1981-1982. Immunostimulating substances from human casein. J. Immunopharmacol. 3:363.
18. Juillerat, M. A., Baechler, R., Berrocal, R., Chanton, S., Scherz, J.-C. and Jost, R. 1989. Tryptic phosphopeptides from whole casein. J. Dairy Res. 56:603.
19. Kálmán, F., Cserháti, T., Valkó, K. and Neubert, K. 1992. Relationships between the reversed-phase chromatographic retention characteristics and physico-chemical parameters of some β-casomorphin peptides. Anal. Chimica Acta 268:247.
20. Kitts, D. D. and Yuan, Y. V. 1992. Caseinophosphopeptides and calcium bioavailability. Trends Food Sci. Tech. 3:31.
21. Lahov, E. and Regelson, W. 1996. Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Fd. Chem. Toxic. 34:131.
22. Loukas, L., Varoucha, D., Zioudrou, C., Straty, R. A. and Klee, W. A. 1983. Opioid activities and structures of α-casein-derived exorphins. Biochem. 22:4567.
23. Maruyama, S., Nakagomi, K., Tomizuka, N. and Suzuki, H. 1985. Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on uterus and the ileum of rats. Agric. Biol. Chem. 51:1581.
24. Maruyama, S. and Suzuki, H. 1982. A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem. 46:1393.
25. Matar, C. and Goulet, J. 1996. β-casomorphin 4 from milk fermented by a mutant of Lactobacillus helveticus. Int. Dairy J. 6,383.
26. Maubois, J. L. and Léonil, J. 1989. Peptides du lait à activité biologique. Lait 69:245.
27. Mazoyer, E., Bal Dit Sollier, C., Drouet, L., Fiat, A.-M., Jollès, P. and Caen, J. 1992. Active peptides from human and cow' s milk proteins effects on platelets function and vessel wall. In "Foods, Nutrition and Immunity". Vol. 1. M. PaubertBraquet, Ch. Dupont and R. Paoletti (Ed.), Dyn. Nutr. Res. Basel. Karger.
28. Meisel, H. 1986. Chemical characterisation and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett. 196:223.
29. Meisel, H. 1993. Casokinins as inhibitors of angiotensin-converting enzyme. In "New Prospectives in Infant Nutrition". Symposium Antwerp 1992. B. Renner and G. Sawatzki (Ed.), Georg Thieme Verlag, Stuttgart. Germany.
30. Meisel, H. 1994. Antibodies from egg yolk of immunised hens against bioactive caseinopeptide (β-casokinin-10). Biol. Chem. Hoppe-Sevler 375:401.
31. Meisel, H., Andersson, H. B., Buhl, K., Erbersdobler, H. F. and Schlimme, E. 1991. Heat-induced changes in casein-derived phosphopeptides.
32. Meisel, H. and Frister, H. 1989. Chemical characterisation of bioactive peptides from in vivo digests of casein. J. Dairy Res. 56:343.
33. Meisel, M. and Schlimme. E. 1994. Inhibitors of angiotensin I-converting enzyme derived from bovine casein (casokinins). In "β-Casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds). VCH-Weinheim. Germany.
34. Migliore-Samour, D., Floc'h, F. and Jollés, P. 1989. Biologically active casein peptides implicated in immunomodulation. J. Dairy Res. 56:357.
35. Migliore-Samour, D. and Jollés, P. 1988. Casein, a prohormone with an immunomodulation role for the newborn? Experientia 44:188.
36. Mullally, M.M., Meisel, H. and FitzGerald, R.J. 1996. Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe-Seyler 377:259.
37. Paakkari, I., Järvinen, A., Antila, P., Mattila, M.J. and Pihlanto-Leppälä, A. 1994. Opioid effects of the milk whey protein-derived peptides α-and β-lactorphin. In "β-Casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds), VCH-Weinheim. Germany.
38. Parker, F., Migliore-Samour, D., Floc'h, F., Zerial, A., Werner, G.H., Jollés, J., Casaretto, M., Zahn, H. and Jollés, P. 1984. Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. Eur. J. Biochem. 145:677.
39. Paroli, E. 1988 Opioid peptides from food (the exorphins). Wld. Rev. Nutr. Diet. 55:58.
40. Pellegrino, L., Battelli, G., Resmini, P., Ferranti, P., Barone, F. and Addeo, F. 1997. Alkaline phosphatase inactivation during Grana Padano cheesemaking and related effects on cheese characterization and ripening. Lait. In press.
41. Petrilli, P., Addeo F. and Chianese, L. 1983. Primary structure of water buffalo casein: tryptic and CNBr peptides. Ital. J. Biochem. 32:336.
42. Pihlanto-Leppälä, A., Antila, P., Mäntsäla P. and Hellman, J. 1994. Opioid peptides produced by in vivo proteolysis of bovine caseins. Int. Dairy J. 4:291.
43. Richardson, B. C. and Mercier, J.-C. 1979. The primary structure of the ovine β-caseins. Eur. J. Biochem. 99:285.
44. th International Dairy Congress. Melbourne, Australia, 18-22 September.
45. Reynolds, E. C., Riley, P. F. and Adamson, N. J. 1994. A selective purification precipitation procedure for multiple phosphoseryl-containing peptides and methods for their identification. Anal. Biochem. 217:277.
46. Roudot-Algaron, F., Le Bars, D., Kerhoas, L., Einhorn, J. and Gripon, J. C. 1994. Phosphopeptides from Comté cheese: nature and origin. J. Food Sci. 59:544.
47. Schlimme, E. and Meisel, H. 1993. Bioactive peptides: structural, physiological and analytical aspects. Newsletter of the IDF, 139, October (Supplement), 57.
48. Schulte-Frohlinde, E., Schimd, R., Brantl, V. and Schusdziarra, V. 1994. Effect of bovine β-casomorphins-4-amide on gastrointestinal transit and pancreatic endocrine function in man. In: "β-Casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds), VCH-Weinheim, Germany.
49. Sekiya, S., Kobayashi, Y., Kita, E., Imamura, Y. and Toyama, S. 1992. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J. Jpn. Soc. Nutr. Food Sci. 45:513.
50. Svedberg, J., De Haas, J., Leimenstoll, G., Paul, F. and Teschemacher, H. 1985. Demonstration of β-casomorphin immunoreactive materials in in vitro digests of bovine milk and in small intestine contents after bovine milk ingestion in adult humans. Peptides 6:825.
51. Tani, F., Shiota, A., Chiba, H. and Yoshikawa, M. 1994. Saerorphin, an opioid peptide derived from bovine serum albumine. In "β-Casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds). VCH-Weinheim, Germany.
52. Teschemacher, H. 1987 Casein derived opioid peptides: physiological significance? Adv. Biosci. 65:41.
53. Teschemacher, H., Koch, G. and Brantl, V. 1994. Milk protein-derived atypical peptides and related compounds with opioid antagonist activity (review). In "β-Casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds), VCH-Weinheim. Germany.
54. Yamamoto. N., Akino, A. and Takano, T. 1994. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77:917.
55. Yamauchi, K. 1992. Biologically functional proteins of milk and peptides derived from milk proteins. Bull. Int. Dairy Federation 272:51.
56. Yamauchi, K., Tomita, M., Giehl, T. J. and Ellison III. R. T. 1993. Antibacterial activity of lactoferrin and a pepsine-derived lactoferrin peptide fragment. Infect. Immun. 61:719.
57. Yen, S. S. C., Quigley, M. E., Reid, R. L., Ropert, J. F. and Cetel, N. S. 1985. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin e prolactin secretion. Am. J. Obstet. Gynecol. 152:485.
58. Yoshikawa, M., Tani, F., Yoshimura, T., and Chiba, H. 1986. Opioid peptides from milk proteins. Agric. Biol. Chem. 50:2419.
59. Zühlke, H., Damert, A., Eckhardt, W., Hübner, G., Kauschke, R., Salazar, R. and Neubert, K. 1994. Influence of β-Casomorphins on the function of the endocrine pancreas. In "β-casomorphins and Related Peptides: Recent Developments". V. Brantl and H. Teschemacher (Eds), VCH-Weinheim, Germany.